TMCnet News
Faruqi & Faruqi, LLP Launches An Investigation Against Moog Inc. (MOG-A) (MOG-B) For Potential Breaches Of Fiduciary Duties By Its Board Of DirectorsNEW YORK --(Business Wire)-- Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Moog Inc. ("Moog" or the "Company") (NYSE: MOG-A and NYSE: MOG-B) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval for an amendment to the Company's 2008 Stock Appreciation Plan. Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on December 13, 2012, the Board of Directors recommends that Moog's shareholders vote to approve an amendment to the Moog Inc. 2008 Stock Appreciation Rights Plan that would increase the total number of stock appreciation rights ("SARs") available for issuance under the Plan by 2,000,000 SARs, from 2,000,000 to 4,000,000. Request more information now by clicking here: www.faruqilaw.com/MOG. There is no cost or obligation to you. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. If you own common stock in Moog Inc. and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/MOG or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2012 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
|
